Search Results 601-610 of 18229 for Immunode

1. PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer - Mayo Clinic

   Known infection with human immunodeficiency virus, Hepatitis B, or Hepatitis C; History of another primary cancer within the last 3 years with the exception ...

2. Conference schedule 2018-2019.xlsx

   Primary Immunodeficiency Edu. Conf. (12-1p). Date. Location. Monthly,. 2nd Mon. Mayo 15-103. Various. Thursdays. MH 5-518. Updated 6/16/19. Mandatory ...

3. A Study of Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) - Mayo Clinic

   Chronic infection or uncontrolled serious illness causing immunodeficiency. A surgical incision that is not healed. Significant hemorrhage (>30 mL/bleeding ...

4. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   history of testing positive to human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome;; hepatitis B virus (HBV) or hepatitis C virus ...

5. Study of bb21217 in Multiple Myeloma - Mayo Clinic

   Known human immunodeficiency virus (HIV) positivity. Known hepatitis A virus (HAV), hepatitis B virus (HBV) or hepatitis C virus (HCV) positivity with ...

6. A Phase III, Randomised Study Of Adjuvant Dato-DXd In Combination With Rilvegostomig Or Rilvegostomig Monotherapy Versus Standard Of Care, Following Complete Tumour Resection, In Participants With Stage I Adenocarcinoma NSCLC Who Are CtDNA-positive Or Have High-risk Pathological Features - Mayo Clinic

   History of active primary immunodeficiency 9. Clinically significant corneal disease. Participating Mayo Clinic locations. Study statuses change often. Please ...

7. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Known positivity for human immunodeficiency virus (HIV); note: baseline testing for HIV is not required; Uncontrolled intercurrent illness including, but not ...

8. A Study Comparing Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

   Patients who are human immunodeficiency virus positive (HIV+) with undetectable HIV viral load are eligible provided they meet all other protocol criteria ...

9. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

   ... immunodeficiency virus (HIV), or acquired immunodeficiency syndrome (AIDS)-related illness. In equivocal cases, participants with a negative viral load may ...

10. A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

    Risk Factors for Pneumonia: immune suppression (e.g. human immunodeficiency virus [HIV], Lupus) or other risk factors for pneumonia (e.g. neurological ...